Cardiovascular Events in Polycystic Ovary Syndrome: Is the Debate Settled for Good?

Damian G Romero^{1

2

3

4}, Licy L Yanes Cardozo^{1

5

2

3

4}

Affiliations

¹ Department of Cell and Molecular Biology, University of Mississippi Medical Center, Jackson, MS 39216, USA.
² Mississippi Center of Excellence in Perinatal Research, University of Mississippi Medical Center, Jackson, MS 39216, USA.
³ Women's Health Research Center, University of Mississippi Medical Center, Jackson, MS 39216, USA.
⁴ Cardio Renal Research Center, University of Mississippi Medical Center, Jackson, MS 39216, USA.
⁵ Department of Medicine, University of Mississippi Medical Center, Jackson, MS 39216, USA.

Editorial

Damian G Romero et al. J Clin Endocrinol Metab. 2021.

. 2021 Nov 19;106(12):e5258-e5259.

doi: 10.1210/clinem/dgab509.

Damian G Romero^{1

2

3

4}, Licy L Yanes Cardozo^{1

5

2

3

4}

¹ Department of Cell and Molecular Biology, University of Mississippi Medical Center, Jackson, MS 39216, USA.
² Mississippi Center of Excellence in Perinatal Research, University of Mississippi Medical Center, Jackson, MS 39216, USA.
³ Women's Health Research Center, University of Mississippi Medical Center, Jackson, MS 39216, USA.
⁴ Cardio Renal Research Center, University of Mississippi Medical Center, Jackson, MS 39216, USA.
⁵ Department of Medicine, University of Mississippi Medical Center, Jackson, MS 39216, USA.

No abstract available

Keywords: cardiovascular events; cardiovascular risk factors; polycystic ovary syndrome.

Comment on

Women With Polycystic Ovary Syndrome Have an Increased Risk of Major Cardiovascular Events: a Population Study.
Berni TR, Morgan CL, Rees DA. Berni TR, et al. J Clin Endocrinol Metab. 2021 Aug 18;106(9):e3369-e3380. doi: 10.1210/clinem/dgab392. J Clin Endocrinol Metab. 2021. PMID: 34061968 Free PMC article.

1. Cooney LG, Dokras A. Cardiometabolic risk in polycystic ovary syndrome: current guidelines. Endocrinol Metab Clin North Am. 2021;50(1):83-95. - PubMed
1. Yanes Cardozo LL, Romero DG, Reckelhoff JF. Cardiometabolic features of polycystic ovary syndrome: role of androgens. Physiology (Bethesda). 2017;32(5):357-366. - PMC - PubMed
1. Lo JC, Feigenbaum SL, Yang J, Pressman AR, Selby JV, Go AS. Epidemiology and adverse cardiovascular risk profile of diagnosed polycystic ovary syndrome. J Clin Endocrinol Metab. 2006;91(4):1357-1363. - PubMed
1. Glintborg D, Hass Rubin K, Nybo M, Abrahamsen B, Andersen M. Morbidity and medicine prescriptions in a nationwide Danish population of patients diagnosed with polycystic ovary syndrome. Eur J Endocrinol. 2015;172(5):627-638. - PubMed
1. Ramezani Tehrani F, Amiri M, Behboudi-Gandevani S, Bidhendi-Yarandi R, Carmina E. Cardiovascular events among reproductive and menopausal age women with polycystic ovary syndrome: a systematic review and meta-analysis. Gynecol Endocrinol. 2020;36(1):12-23. - PubMed